Univalor Announces Important Transaction with CogniSens
Montreal, November 17, 2015 – Univalor is pleased to announce the conclusion of a transaction with the Montreal-based company CogniSens whereby Univalor has transferred, in exchange for share capital, certain intellectual property assets used by CogniSens.
Jacques Simoneau, CEO of Univalor, said: “This transaction affirms our confidence in CogniSens and its management team, as well as in the quality and the potential of the products it commercializes. These products were developed based upon technologies resulting from research at the Université de Montréal. We have been in a partnership with CogniSens since 2008 and we are excited to be participating in this important stage in the company’s growth.”
“Our company’s growth is attributed to an increased awareness of the market relevance of our unique technologies. This transaction will enable us to expand our commercialization and distribution in all of our markets. It will also allow us to further our partnerships with military and sports performance market leaders as well as with prominent health and wellness research centres.”, underlined the CEO of NeuroTracker.
Univalor is a university technology transfer organization. For more than 13 years, Univalor has strived to develop and commercialize scientific discoveries and technology innovations resulting from the work of over 2,600 researchers of the Université de Montréal and its affiliated health centres, as well as of Polytechnique Montréal and of HEC Montréal. The Ministère de l’Économie, Innovation et Exportations (MEIE) participates in the financing of the operations of Univalor. By creating links between the university and the business sector, Univalor contributes to make businesses more competitive, to generate revenue for research, and, most importantly, to enrich society. www.univalor.ca
About CogniSens Inc.
CogniSens Inc. is a private Montreal-based company specializing in the application of neurological technologies to enhance cognitive capabilities. These technologies derive from over 20 years of research at the Visual Psychophysics and Perception Laboratory of the Université de Montréal under the direction of Dr. Jocelyn Faubert, an internationally renowned neuroscientist and Chief Science Officer of CogniSens. CogniSens has developed a suite of revolutionary training and measurement applications. The NeuroTracker offers cognitive training programs that increase situational awareness and improve decision-making to enhance human performance and quality of life. www.NeuroTracker.net
*Elite athletes and skilled specialists from teams and organizations like these. All trademarks and logos are intellectual property and owned by the respective organizations listed, not NeuroTracker.*
** NeuroTracker is used in various medical research and is currently undergoing regulatory approval processes. Until such approval is complete, NeuroTracker is not intended to be substituted for professional medical advice, diagnosis, or treatment.**